Incorporation of lysozyme into cellulose nanocrystals stabilized β-chitosan nanoparticles with enhanced antibacterial activity

Carbohydr Polym. 2020 May 15:236:115974. doi: 10.1016/j.carbpol.2020.115974. Epub 2020 Feb 11.

Abstract

Cellulose nanocrystals (CNCs) were added to lysozyme (Lys) loaded β-chitosan (β-CS) nanoparticles (NPs) based on ionic gelation technique for enhancing their antibacterial stability. Particle size of CNCs stabilized Lys loaded low (L) and high (H) molecular weight (MW) β-CS NPs reached 140.93 and 284.03 nm with encapsulation efficacy (EE) of 59.38 and 51.23 %, respectively. CNCs stabilized Lys loaded LMW β-CS NPs with smaller particle size showed higher antibacterial activity against E. coli and L. innocua than that of LMW β-CS NPs and Lys loaded LMW β-CS NPs. Inhibition zones (IZ) of CNCs stabilized Lys loaded LMW β-CS NPs against E. coli and L. innocua were 13.29 and 15.29 mm, respectively. in vitro release study conducted at pH 4.5 and 7.4 showed that CNCs stabilized Lys loaded β-CS NPs sustained the release of Lys over 12 h. CNCs, as stabilizers and fillers, enhanced and extended antibacterial property of Lys loaded β-CS NPs through electrostatic interaction and colloidal stability. It was demonstrated that CNCs stabilized Lys loaded β-CS NPs could be used as packaging material for shelf life extension.

Keywords: Antibacterial activity; Cellulose nanocrystals; Lysozyme; Mechanisms; β-Chitosan nanoparticles.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Carbohydrate Sequence
  • Cellulose / chemistry*
  • Chitosan / chemistry*
  • Drug Carriers / chemistry*
  • Escherichia coli / drug effects
  • Listeria / drug effects
  • Microbial Sensitivity Tests
  • Muramidase / pharmacology*
  • Nanoparticles / chemistry*

Substances

  • Anti-Bacterial Agents
  • Drug Carriers
  • Cellulose
  • Chitosan
  • Muramidase

Supplementary concepts

  • Listeria innocua